An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe Asthma

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

NCT05097287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Dupilumab for Severe Asthma in a Real Life Setting

NCT04022447 ·Status: COMPLETED

Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma

NCT02573233 ·Status: COMPLETED ·Phase: PHASE2

Real Life Experience Survey of Dupilumab in the Netherlands

NCT05331755 ·Status: COMPLETED

An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma

NCT01854047 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

NCT06191315 ·Status: RECRUITING ·Phase: PHASE3

Withdrawal of Dupilumab in Severe Asthma

NCT06818019 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma

NCT04502862 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)

NCT02414854 ·Status: COMPLETED ·Phase: PHASE3

A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)

NCT05070663 ·Status: COMPLETED

Investigating Dupilumab's Effect in Asthma by Genotype

NCT03694158 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Safety and Efficacy of SA09012 in Asthma

NCT01740986 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Dupilumab in Children With Uncontrolled Asthma

NCT02948959 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

NCT01312961 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

NCT04203797 ·Status: COMPLETED ·Phase: PHASE4

Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy

NCT03629782 ·Status: COMPLETED

A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.

NCT01704495 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma

NCT00946569 ·Status: COMPLETED ·Phase: PHASE2

Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

NCT04743791 ·Status: RECRUITING ·Phase: PHASE4

Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)

NCT03560466 ·Status: COMPLETED ·Phase: PHASE3

Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)

NCT03620747 ·Status: COMPLETED ·Phase: PHASE3

Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database

NCT05136547 ·Status: COMPLETED

The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world Study

NCT06851403 ·Status: ENROLLING_BY_INVITATION

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

NCT00255255 ·Status: COMPLETED ·Phase: PHASE3

Cross-sectional Study for Identification and Description of Severe Asthma Patients

NCT02293265 ·Status: COMPLETED ·Phase: PHASE3